Axa’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-172,575
| Closed | -$2.03M | – | 1145 |
|
|
2023
Q2 | $2.03M | Sell |
172,575
-3,500
| -2% | -$39.8K | 0.01% | 726 |
|
|
2023
Q1 | $2.02M | Buy |
176,075
+2,600
| +1% | +$32.2K | 0.01% | 762 |
|
|
2022
Q4 | $2.16M | Hold |
173,475
| – | – | 0.01% | 762 |
|
|
2022
Q3 | $2.28M | Sell |
173,475
-54,500
| -24% | -$805K | 0.01% | 737 |
|
|
2022
Q2 | $3.18M | Sell |
227,975
-76,771
| -25% | -$1.03M | 0.01% | 685 |
|
|
2022
Q1 | $4.54M | Sell |
304,746
-91,500
| -23% | -$1.25M | 0.01% | 667 |
|
|
2021
Q4 | $5.37M | Buy |
396,246
+79,417
| +25% | +$1.12M | 0.01% | 649 |
|
|
2021
Q3 | $4.66M | Buy |
316,829
+47,700
| +18% | +$806K | 0.01% | 698 |
|
|
2021
Q2 | $4.9M | Sell |
269,129
-61,400
| -19% | -$1.09M | 0.01% | 714 |
|
|
2021
Q1 | $5.74M | Buy |
330,529
+5,400
| +2% | +$95K | 0.02% | 676 |
|
|
2020
Q4 | $5.65M | Hold |
325,129
| – | – | 0.02% | 665 |
|
|
2020
Q3 | $4.48M | Hold |
325,129
| – | – | 0.02% | 654 |
|
|
2020
Q2 | $4.69M | Buy |
325,129
+95,900
| +42% | +$1.26M | 0.02% | 634 |
|
|
2020
Q1 | $2.5M | Sell |
229,229
-39,517
| -15% | -$729K | 0.01% | 685 |
|
|
2019
Q4 | $5.74M | Buy |
268,746
+14,200
| +6% | +$318K | 0.02% | 585 |
|
|
2019
Q3 | $5.84M | Sell |
254,546
-32,802
| -11% | -$700K | 0.02% | 598 |
|
|
2019
Q2 | $5.66M | Sell |
287,348
-81,598
| -22% | -$1.59M | 0.02% | 618 |
|
|
2019
Q1 | $7.18M | Sell |
368,946
-54,900
| -13% | -$1.04M | 0.03% | 542 |
|
|
2018
Q4 | $6.99M | Buy |
423,846
+49,800
| +13% | +$1M | 0.03% | 513 |
|
|
2018
Q3 | $8.65M | Buy |
374,046
+24,013
| +7% | +$544K | 0.03% | 517 |
|
|
2018
Q2 | $7.61M | Sell |
350,033
-180,310
| -34% | -$3.52M | 0.03% | 534 |
|
|
2018
Q1 | $9.36M | Buy |
530,343
+66,900
| +14% | +$1.18M | 0.04% | 465 |
|
|
2017
Q4 | $8.7M | Buy |
463,443
+293,894
| +173% | +$5.85M | 0.03% | 510 |
|
|
2017
Q3 | $3.72M | Buy |
+169,549
| New | +$3.83M | 0.02% | 696 |
|
|
2016
Q1 | – | Sell |
-7,832
| Closed | -$158K | – | 1398 |
|
|
2015
Q4 | $158K | Hold |
7,832
| – | – | ﹤0.01% | 1200 |
|
|
2015
Q3 | $182K | Buy |
+7,832
| New | +$200K | ﹤0.01% | 1229 |
|
|
2015
Q1 | – | Sell |
-54,085
| Closed | -$1.64M | – | 1483 |
|
|
2014
Q4 | $1.64M | Buy |
54,085
+1,721
| +3% | +$47.4K | 0.01% | 845 |
|
|
2014
Q3 | $1.27M | Buy |
52,364
+2,364
| +5% | +$65.6K | 0.01% | 855 |
|
|
2014
Q2 | $1.44M | Buy |
50,000
+16,000
| +47% | +$465K | 0.01% | 853 |
|
|
2014
Q1 | $948K | Hold |
34,000
| – | – | ﹤0.01% | 930 |
|
|
2013
Q4 | $889K | Buy |
34,000
+13,000
| +62% | +$335K | ﹤0.01% | 942 |
|
|
2013
Q3 | $483K | Sell |
21,000
-6,400
| -23% | -$158K | ﹤0.01% | 1004 |
|
|
2013
Q2 | $715K | Buy |
+27,400
| New | +$791K | ﹤0.01% | 895 |
|
Other funds holding SBRA
Axa's SBRA Position: Q3 2023 in Review
Axa sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 172,575 shares — an estimated $2.03M sold.
Axa first reported a position in SBRA in Q2 2013 and held it in 33 quarters. The position peaked at $9.36M in Q1 2018. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.
- Axa reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
- Axa sold 172,575 Sabra Healthcare REIT shares in Q3 2023, an estimated $2.03M.
- Axa first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 33 quarters.
- Axa's Sabra Healthcare REIT position peaked at $9.36M in Q1 2018.
- 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.
Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.